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GENERAL COMMENTS
This paper presents a protocol for the systematic review of selfefficacy measures that are used with alcohol and/or drug users. The authors make the point that self-efficacy for resisting drinking or drug use in high-risk for use situations is a key construct in the treatment of alcohol and drug treatment, and that the psychometrics of instruments used to measure self-efficacy need to be established. To do this review the authors propose to use the PICOS strategy as a guide for searching Medline, Pubmed, SCOPUS, and CINAHL, and to follow-up on those results to acquire other studies using a snowball method. Criteria for inclusion of studies of self-efficacy instrument development are detailed, as is the process for establishing that a study meets the criteria. Finally, the authors note that the review of the self-efficacy instruments will contain descriptive information regarding participant characteristics, psychometric properties, and a discussion of the clinical utility of each measure. The resulting review would provide an overview of the instruments developed to date, and thereby provide information to clinicians and researchers regarding the appropriateness of different measures of drinking or drug use resistance self-efficacy. The current protocol is supposed to be written in accordance with PRISMA-P guidelines.
Despite the usefulness of the proposed project and the logical approach evidenced in the protocol, there are aspects to this paper that should be addressed. The Background proposed by the authors to justify this protocol is inadequate. The supposed aim is to justify a systematic look at the measurement of self-efficacy, but the concept of self-efficacy is barely mentioned, and not even clearly defined as the concept relates to substance abuse or its treatment.
The paper itself is a bit difficult to read, owing to the errors in English made by the authors. The first full paragraph on p. 4 is one long sentence, and a non-sequitur at that. In several places the authors use the wrong prepositions or other incorrect usage. These problems with English occur so frequently that it becomes difficult to determine what the authors are proposing.
On p. 5 they write "The Census-Based Standards for the selection of the COSMIN checklist will be used to assess the methodological quality of the included studies." What they actually mean is, "The COnsensus-based Standards for the selection of health status Measurement Instruments (COSMIN) checklist will be used…" Difficulty with understanding the protocol is compounded by references that seem to be misplaced (e.g., reference # 15 really seems to refer to citation # 14).
Finally, although the authors state that they will use PRISMA-P guidelines, they did not quite do that. The PRISMA-P guidelines are intended to be guidelines for the reporting of protocols for conducting systematic reviews. The guidelines specify that the protocol should contain certain sections to insure that a resulting review will be of high quality. The authors did include information relevant to many of these guidelines, but not all.
For instance, although the authors indicated that they had described anticipated methods for assessing risk of bias in individual studies, no such discussion appears in this paper. Nor is there mention as to how strength of evidence will be calculated or discussed. It is never made clear what the authors think a good self-efficacy scale should do, or what it should be used for.
I am in favor of a systematic review of measures of alcohol and drug resistance self-efficacy. The measures in use right now are adequate, but might be improved, and there might be measures of which I am unaware. A systematic review might effectively review the literature in this area and provide new insights into the nature of self-efficacy and how it is measured. The protocol reviewed here does not seem to do those things.
VERSION 1 -AUTHOR RESPONSE
REVIEWER -1 1. This systematic review protocol is trying to elucidate an underexplored topic, self-efficacy, in alcohol and substance use disorders. However, the standard of written English causes a barrier to understand and assess this protocol. It would be beneficial for the authors to seek for language assistance.
R. A professional native English-speaking translator and text editor has edited the text for better clarity with regard to the language issue.
2. The study title does not reflect the research question.
R. The title has been altered to clarify the research question (present validated assessment tools for measuring self-efficacy in users of alcohol and other substances).
3. The reviewer noticed that this protocol looks similar or at least might overlap a protocol registered by the same group in 2015 (PROSPERO CRD 42015020831). Could the authors explain the difference between these two protocols in details? Why separate them into small projects rather than updating the existing one? Furthermore, what happened to the previous protocol?
R. The overlap of the protocols can be explained. The group of researchers in 2015 intended to perform a systematic review with a similar purpose. However, changes in the research group and further discussions on the methodological design occurred, resulting in significant changes in the topic to be explored. Thus, the team judged it necessary to register a new protocol due to the differences in relation to the initial proposal.
4. Please explain why only studies that present a positive classification will be included (line 39, page 5)? What is a positive classification? Similar to an arbitrary score for the clinical usefulness. What are these based on? Won't these be a kind of selection bias?
R. The authors judged it necessary to rewrite the paragraph and explain the concept of "positive classification" (line 39, paragraph 5). "Positive classification" was used to say that only assessment tools considered adequate based on the COSMIN checklist would be included.
5. Please articulate the method for synthesising data.
R. The researchers have rewritten the sections "evaluation of clinical usefulness of assessment tools" and "data synthesis" to clarify the presentation of the results.
6. How will the authors weight and apply the methodological quality and clinical usefulness for the recommendation?
R. Methodological quality will be measured using the COSMIN checklist described in the section "Appraisal of methodological quality of selected articles". Clinical usefulness will be evaluated based on the criteria proposed by Tyson and Brown (section: "Evaluation of clinical usefulness of assessment tools").
7. How will the authors deal with instruments that might focus on different aspects of substance abuse, treatment goals or specific populations?
R.Only assessment tools designed to measure self-efficacy related to resisting the urge to use drugs in high-risk situations will be included. Instruments for measuring self-efficacy regarding adherence to treatment, coping, etc. will not be considered. Moreover, assessment tools related to treatment goals and those directed at specific populations will not be considered, as such issues are not the objective of the proposed review.
8. Please articulate data extraction items for included studies/instruments.
R. The authors have added the section "Tracking, data extraction, and content comparison analysis" to explain the data extraction process.
9. Will the authors record any reasons for those excluded studies?
R. Yes, the reasons for exclusion will be presented in a PRISMA flow chart, as described in the section "Tracking, data extraction, and content comparison analysis" (paragraph 4).
REVIEWER -2
Comment: Despite the usefulness of the proposed project and the logical approach evidenced in the protocol, there are aspects to this paper that should be addressed. The Background proposed by the authors to justify this protocol is inadequate. The supposed aim is to justify a systematic look at the measurement of self-efficacy, but the concept of self-efficacy is barely mentioned, and not even clearly defined as the concept relates to substance abuse or its treatment.
R. The researchers have reorganized the theoretical context for the protocol, with a better description of the concept of self-efficacy in light of the phenomenon of substance abuse and dependence.
Comment: The paper itself is a bit difficult to read, owing to the errors in English made by the authors. The first full paragraph on p. 4 is one long sentence, and a non-sequitur at that. In several places the authors use the wrong prepositions or other incorrect usage. These problems with English occur so frequently that it becomes difficult to determine what the authors are proposing.
Comment: On p. 5 they write "The Census-Based Standards for the selection of the COSMIN checklist will be used to assess the methodological quality of the included studies." What they actually mean is, "The COnsensus-based Standards for the Selection of health status Measurement Instruments (COSMIN) checklist will be used…" R. The reviewer is correct. The sentence has been rewritten accordingly.
Comment: Difficulty with understanding the protocol is compounded by references that seem to be misplaced (e.g., reference # 15 really seems to refer to citation # 14).
R. The references have been verified and corrected when necessary.
Comment: Finally, although the authors state that they will use PRISMA-P guidelines, they did not quite do that. The PRISMA-P guidelines are intended to be guidelines for the reporting of protocols for conducting systematic reviews. The guidelines specify that the protocol should contain certain sections to insure that a resulting review will be of high quality. The authors did include information relevant to many of these guidelines, but not all. For instance, although the authors indicated that they had described anticipated methods for assessing risk of bias in individual studies, no such discussion appears in this paper. Nor is there mention as to how strength of evidence will be calculated or discussed. It is never made clear what the authors think a good self-efficacy scale should do, or what it should be used for.
R. Strategies for the reduction of the risk of bias have been added to the section "Search strategy". The strength of evidence will be evaluated in accordance with GRADE (section: "Data synthesis"). The researchers have added the criteria used for considering the adequacy of the assessment tools (section: "Data synthesis").
Comment: I am in favor of a systematic review of measures of alcohol and drug resistance selfefficacy. The measures in use right now are adequate, but might be improved, and there might be measures of which I am unaware. A systematic review might effectively review the literature in this area and provide new insights into the nature of self-efficacy and how it is measured. The protocol reviewed here does not seem to do those things.
R. The authors hope that the revised version of the protocol successfully addresses the reviewer's concerns.
VERSION 2 -REVIEW
